Shop All Access Bio

CareStart Rapid Antigen Test Kit (FDA/EUA)

4.9
| TRUSTED BY 50,000+
Regular price $395.00
Sale price $395.00 Regular price $500.00
Unit price
Sale
  • Lateral flow assay
  • Detect SARS-CoV-2 nucleocapsid protein antigen
  • Rapid results within 10-15 minutes
  • For use under the Emergency Use Authorization (EUA)
Free Shipping over $250. Get it shipped today.

Pro-Tip

Pair your CareStart™ Rapid Antigen Test Kit with CofixRX™ Anti-Pathogen (Povidone Iodine) Nasal Cleanse for an extra layer of protection. CofixRX is formulated with povidone-iodine to help reduce exposure to airborne germs—perfect for added peace of mind during cold and flu season!

CareStart™ Rapid Antigen Test Kit (FDA/EUA)

CareStart™ Rapid Antigen Test Kit (FDA/EUA)

Because access is everything.

Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. Based on the greatest needs and the potential to do the most good, we work with partners across the world.

Frequently asked questions

Find clear, helpful answers to the most common questions about CareStart™ Rapid Antigen Test Kit (FDA/EUA).

Still need help? Chat with us.

The CareStart™ COVID-19 Antigen is a type of test called an antigen test. Antigen tests are designed to detect proteins from the virus that causes COVID-19 in nasopharyngeal or anterior nasal swab samples collected by a healthcare provider.

Testing of your specimen(s) will help find out if you may have COVID-19.

If you have a positive test result with the CareStart™ COVID-19 Antigen test, it is very likely that you have COVID-19 because proteins from the virus that causes COVID-19 were found in your sample. Therefore, it is also likely that you may be placed in isolation to avoid spreading the virus to others. You should follow CDC guidance to reduce the potential transmission of disease.

Eighty-three percent of adults and 87% of children were asymptomatic. CareStart sensitivity/specificity were 84.8% (95% confidence interval [CI], 71.1–93.7)/97.2% (95% CI, 92.0–99.4) and 85.7% (95% CI, 42.1–99.6)/89.5% (95% CI, 66.9–98.7) in adults and children, respectively, within 5 days of symptoms.

Recently Viewed Products

About Access Bio
Because access is everything.
Access Bio® provides accurate, over-the-counter antigen tests designed to detect infectious diseases quickly and effectively. Whether at home, work, or school, these easy-to-use tests help reduce spread and support early intervention when it matters most. Backed by scientific innovation, Access Bio ensures confidence in every result. Shop Access Bio® antigen tests now on Pharmalynk – providing trusted access to low-impact healthcare essentials.
Access Bio image